Literature DB >> 3160903

Serotonin in body fluids: characterization of human plasmatic and cerebrospinal fluid pools by means of a new HPLC method.

F Artigas, M J Sarrias, E Martínez, E Gelpí.   

Abstract

A new HPLC technique for the analysis of picomolar amounts of serotonin (5HT) in plasma and cerebrospinal fluid (CSF) is described. Bufotenin is used as internal standard. Detection is achieved electrochemically or fluorimetrically. The detection limit can be estimated as 50 pg 5HT/mL of either fluid (0.3 picomolar). The method is used to characterize a non-particulate pool of 5HT which is clearly distinct of the platelet pool. Administration of parachlorophenylalanine (PCPA) 300 mg/kg to rats leads to a 90% reduction in the plasmatic pool whereas platelet 5HT is only slightly decreased (3rd day after PCPA) or even increased (7th day after PCPA). Human concentration (n = 15) of 5HT in plasma is 2.6 +/- 0.9 ng/mL (X +/- S.D.). The application of the method to CSF of neurological patients reveals 5HT concentrations ranging from 93 to 962 pg/mL.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3160903     DOI: 10.1016/0024-3205(85)90406-0

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  10 in total

1.  Proceedings of the British Pharmacological Society. 12-14 September 1990, Belfast.

Authors: 
Journal:  Br J Clin Pharmacol       Date:  1991-02       Impact factor: 4.335

2.  Postprandial plasma 5-hydroxytryptamine in diarrhoea predominant irritable bowel syndrome: a pilot study.

Authors:  C P Bearcroft; D Perrett; M J Farthing
Journal:  Gut       Date:  1998-01       Impact factor: 23.059

3.  Increased turnover of serotonin in children with pulmonary hypertension secondary to congenital heart disease.

Authors:  J Breuer; A Georgaraki; L Sieverding; W Baden; J Apitz
Journal:  Pediatr Cardiol       Date:  1996 Jul-Aug       Impact factor: 1.655

4.  Multiplexed Monitoring of Neurochemicals via Electrografting-Enabled Site-Selective Functionalization of Aptamers on Field-Effect Transistors.

Authors:  Zan Gao; Guangfu Wu; Yang Song; Huijie Li; Yuxuan Zhang; Michael J Schneider; Yingqi Qiang; Jackson Kaszas; Zhengyan Weng; He Sun; Bryan D Huey; Rebecca Y Lai; Yi Zhang
Journal:  Anal Chem       Date:  2022-06-09       Impact factor: 8.008

5.  Effects of monoamine uptake inhibitors on extracellular and platelet 5-hydroxytryptamine in rat blood: different effects of clomipramine and fluoxetine.

Authors:  J Ortiz; F Artigas
Journal:  Br J Pharmacol       Date:  1992-04       Impact factor: 8.739

6.  Increased plasma free serotonin but unchanged platelet serotonin in bipolar patients treated chronically with lithium.

Authors:  F Artigas; M J Sarrias; E Martínez; E Gelpí; E Alvarez; C Udina
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

7.  Differential pulse voltammetry and chronoamperometry as analytical tools for epinephrine detection using a tyrosinase-based electrochemical biosensor.

Authors:  Sylwia Baluta; Francesca Meloni; Kinga Halicka; Adam Szyszka; Antonio Zucca; Maria Itria Pilo; Joanna Cabaj
Journal:  RSC Adv       Date:  2022-09-06       Impact factor: 4.036

8.  Enzymatic Platforms for Sensitive Neurotransmitter Detection.

Authors:  Sylwia Baluta; Dorota Zając; Adam Szyszka; Karol Malecha; Joanna Cabaj
Journal:  Sensors (Basel)       Date:  2020-01-11       Impact factor: 3.576

9.  Cost-Effective Electrochemical Activation of Graphitic Carbon Nitride on the Glassy Carbon Electrode Surface for Selective Determination of Serotonin.

Authors:  Vijayaraj Kathiresan; Thenmozhi Rajarathinam; Seulah Lee; Suhkmann Kim; Jaewon Lee; Dinakaran Thirumalai; Seung-Cheol Chang
Journal:  Sensors (Basel)       Date:  2020-10-26       Impact factor: 3.576

10.  Differential Potency of Venlafaxine, Paroxetine, and Atomoxetine to Inhibit Serotonin and Norepinephrine Reuptake in Patients With Major Depressive Disorder.

Authors:  Fahad Aldosary; Sandhaya Norris; Philippe Tremblay; Jonathan S James; James C Ritchie; Pierre Blier
Journal:  Int J Neuropsychopharmacol       Date:  2022-04-19       Impact factor: 5.176

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.